Boston Scientific’s new stent is “backed by flawed research,” according to an analysis by the WSJ’s Keith Winstein in this morning’s paper.
The WSJ article questions the results of a key trial of the Taxus Liberte stent, which is expected to be approved by the FDA in the coming months. The study, which found the [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment